173 related articles for article (PubMed ID: 23860040)
1. Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.
MacLeod R; Beach A; Henriques S; Knopp J; Nelson K; Kerzin-Storrar L
Eur J Hum Genet; 2014 Mar; 22(3):396-401. PubMed ID: 23860040
[TBL] [Abstract][Full Text] [Related]
2. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):47-55. PubMed ID: 18189288
[TBL] [Abstract][Full Text] [Related]
3. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Frets PG; Zoeteweij MW; Losekoot M; van Haeringen A; Niermeijer MF; Passchier J
J Med Genet; 1997 May; 34(5):382-90. PubMed ID: 9152835
[TBL] [Abstract][Full Text] [Related]
4. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
[TBL] [Abstract][Full Text] [Related]
5. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study.
Godino L; Jackson L; Turchetti D; Hennessy C; Skirton H
Eur J Hum Genet; 2018 Jan; 26(1):44-53. PubMed ID: 29162934
[TBL] [Abstract][Full Text] [Related]
6. Disclosing genetic test results to family members.
Hamilton RJ; Bowers BJ; Williams JK
J Nurs Scholarsh; 2005; 37(1):18-24. PubMed ID: 15813582
[TBL] [Abstract][Full Text] [Related]
7. Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.
Tercyak KP; Bronheim SM; Kahn N; Robertson HA; Anthony BJ; Mays D; O'Neill SC; Peterson SK; Miesfeldt S; Peshkin BN; DeMarco TA
Transl Behav Med; 2019 May; 9(3):493-503. PubMed ID: 31094441
[TBL] [Abstract][Full Text] [Related]
8. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
10. Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders.
Beery TA; Williams JK
Genet Test; 2007; 11(2):111-23. PubMed ID: 17627380
[TBL] [Abstract][Full Text] [Related]
11. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives.
Taylor SD
Soc Sci Med; 2004 Jan; 58(1):137-49. PubMed ID: 14572927
[TBL] [Abstract][Full Text] [Related]
12. Help or hindrance: young people's experiences of predictive testing for Huntington's disease.
Forrest Keenan K; McKee L; Miedzybrodzka Z
Clin Genet; 2015 Jun; 87(6):563-9. PubMed ID: 24891047
[TBL] [Abstract][Full Text] [Related]
13. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
Katapodi MC; Munro ML; Pierce PF; Williams RA
Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
[TBL] [Abstract][Full Text] [Related]
14. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.
Arning L; Witt CN; Epplen JT; Stemmler S
J Huntingtons Dis; 2015; 4(1):87-98. PubMed ID: 26333260
[TBL] [Abstract][Full Text] [Related]
15. Familial breast cancer genetic testing in the West of Ireland.
McVeigh TP; Irwin R; Cody N; Miller N; McDevitt T; Sweeney KJ; Green A; Kerin MJ
Ir J Med Sci; 2014 Jun; 183(2):199-206. PubMed ID: 23884708
[TBL] [Abstract][Full Text] [Related]
16. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
Dean M
Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing and the family.
Van Riper M
J Midwifery Womens Health; 2005; 50(3):227-33. PubMed ID: 15895001
[TBL] [Abstract][Full Text] [Related]
18. Predictive genetic testing for breast cancer and Huntington's disease: the opinions of midwives and nurses in Flanders.
Welkenhuysen M; Evers-Kiebooms G
Community Genet; 2003; 6(2):104-13. PubMed ID: 14560071
[TBL] [Abstract][Full Text] [Related]
19. Genetic Counselling and Narrative Practices: A Model of Support following a "Negative" Predictive Test for Huntington's Disease.
MacLeod R; Moldovan R; Stopford C; Ferrer-Duch M
J Huntingtons Dis; 2018; 7(2):175-183. PubMed ID: 29562548
[TBL] [Abstract][Full Text] [Related]
20. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
Kwong A; Chen JW; Shin VY
Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
